SCHEMBL7793029

SCHEMBL7793029

COc1ccc(C(=NO)C(F)(F)F)cc1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.36
HPGD P15428 3/20 0.36
GAA P10253 4/20 0.36
IDO1 P14902 2/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK10 P53779 2/20 0.34
TP53 P04637 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
THRB P10828 1/20 0.34
TSHR P16473 2/20 0.33
ADRB2 P07550 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793022 1.00 ALDH1A1 (0.36) ALDH1A1HPGDGAAIDO1ALOX15
SCHEMBL7797928 0.83 ALDH1A1 (0.43) ALDH1A1HPGDGAAMEN1KMT2A
SCHEMBL992580 0.78 GAA (0.45) ALDH1A1GAAALOX15HSD17B10
SCHEMBL992578 0.78 GAA (0.45) ALDH1A1GAAALOX15HSD17B10
SCHEMBL7247135 0.74 GAA (0.54) ALDH1A1HPGDGAAALOX15HSD17B10
SCHEMBL30219459 0.74 GAA (0.54) ALDH1A1HPGDGAAALOX15HSD17B10
SCHEMBL7247134 0.74 GAA (0.54) ALDH1A1HPGDGAAALOX15HSD17B10
SCHEMBL23462893 0.72 IDO1 (0.44) ALDH1A1GAAIDO1TSHRMAPK1
SCHEMBL1145736 0.72 KDM4E (0.46) ALDH1A1GAAIDO1ALOX15HSD17B10
SCHEMBL7799947 0.71 TACR1 (0.43) ALDH1A1IDO1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2001-09-27 US disclosed
US-6110934-A Substituted benzamide derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. (GB) 2000-08-29 US disclosed
EP-1025087-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-08-09 EP disclosed
WO-1999021836-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A ALDH1A1 494/4885HPGD 589/4885GAA 2863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.